Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps (NASDAQ:SMTI)

Core Insights - Shares of Sanara MedTech Inc. (SMTI) have sharply declined following the release of the company's Q3 earnings, with a nearly 40% drop for the year [1] Company Performance - The surgical segment of Sanara MedTech has been fast-growing and profitable, but this growth has been overshadowed by recent stock performance [1]